Overview

A Study to Evaluate the Drug Interaction of ASP015K and Tacrolimus

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to characterize the effect of multiple doses of ASP015K on the pharmacokinetics of a single oral dose or a single intravenous (IV) dose of tacrolimus.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Peficitinib
Tacrolimus